| # | Drug | Count |
|---|---|---|
| 0 | IBRUTINIB | 30 |
| 1 | ADALIMUMAB | 21 |
| 2 | RISANKIZUMAB-RZAA | 21 |
| 3 | ACETAMINOPHEN | 16 |
| 4 | ALBUTEROL SULFATE | 16 |
| 5 | ALENDRONATE SODIUM | 16 |
| 6 | ETANERCEPT | 16 |
| 7 | DUPILUMAB | 15 |
| 8 | ERGOCALCIFEROL | 15 |
| 9 | ASPIRIN | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HEMORRHOIDAL COOLING GEL | 1 | 0.0400 |
| 1 | SODIUM CITRATE DIHYDRATE | 1 | 0.0244 |
| 2 | FENOPROFEN CALCIUM | 1 | 0.0204 |
| 3 | TAVABOROLE | 1 | 0.0143 |
| 4 | BABY PETROLEUM JELLY | 1 | 0.0097 |
| 5 | WHITE PETROLATUM JELLY | 1 | 0.0096 |
| 6 | THIOTHIXENE | 1 | 0.0046 |
| 7 | CAMPHOR, EUCALYPTUS OIL, MENTHOL | 1 | 0.0043 |
| 8 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | 1 | 0.0042 |
| 9 | FEXOFENADINE HYDROCHLORIDE TABLETS | 1 | 0.0039 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 36 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 27 |
| 3 | Benzodiazepine [EPC] | 17 |
| 4 | Corticosteroid [EPC] | 17 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 15 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 14 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| 8 | Janus Kinase Inhibitor [EPC] | 12 |
| 9 | Vitamin C [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxaborole Antifungal [EPC] | 1 | 0.0143 |
| 1 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 2 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 8 | 0.0006 |
| 4 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 5 | Semifluorinated Alkane [EPC] | 1 | 0.0004 |
| 6 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 8 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 9 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |